Progress in Oncology 2002Vincent T. DeVita, Samuel Hellman, Steven A. Rosenberg Jones & Bartlett Learning, 2003 - 390 páginas The second volume in the annual series, Progress In Oncology 2002 highlights progress in the basic and clinical aspects of oncology and is reviewed by leaders in the field. Comprehensive reviews on important advances in the previous year are selected to help cancer research scientists and oncologists stay up-to-date with high impact progress across all disciplines in oncology. |
Índice
Modulation of the Inhibitory Effects of CTLA4 in the | 23 |
New Approaches to Gene Therapy for Cancer | 36 |
Principles and Progress | 54 |
The Role of the AntiApoptotic Survivin Gene in | 81 |
Imatinib STI571 Gleevec as Therapy to Target the | 95 |
Epidermal Growth Factor Receptor Blockade and the | 113 |
The Development of Antiangiogenic Agents for the Clinic | 129 |
Cyclooxygenase2 Inhibitors in Colorectal Cancer | 158 |
Prognostic Factors and Staging of Melanoma | 214 |
Current Controversies in Oncology | 251 |
Vaccination | 270 |
Smoking Cessation Strategies | 293 |
Targeting Populations | 313 |
The Utility of Mammography for Women Aged 40 to 50 | 328 |
The Utility of Mammography for Women 40 to 50 Years | 346 |
| 373 | |
Late Effects of Childhood Cancer Therapy | 171 |
The Use of Spiral Computed Tomography in Lung Cancer | 202 |
Términos y frases comunes
Acad Sci USA activity adenovirus agents analysis angiogenesis inhibitor angiostatin anti-tumor antiangiogenic antibodies antigen apoptosis benefit Biol bladder cancer breast cancer cell carcinoma cellular cervical cancer chemoprevention chemotherapy childhood cancer Clin Cancer Res Clin Oncol clinical trials colon colorectal combination cytotoxic detection disease dose drug effects efficacy EGFR endostatin endothelial cells enhanced epidermal growth factor expression gene therapy genetic GIST growth factor receptor human papillomavirus imatinib immune induced infection inhibition interventions intratumoral irradiation lesions lung cancer lymph node malignant mammograms mammography metastases mice molecular mortality mutations Natl Acad Sci Natl Cancer Inst neoplasia nodules normal pathway patients peptide potential primary melanoma Proc Natl Acad prognostic factors proliferation prostate protein proteomic radiation radiotherapy regression replication replication-competent response risk screening smoking cessation studies survival survivin T-cell target therapeutic tissue toxicity treatment tumor cells tumor growth tyrosine kinase ulceration vaccine vector viral virus viruses vivo women aged xenografts